SCHEMBL3775697

SCHEMBL3775697

N=C(N)Nc1ccc2c(c1)Cc1ccc(NC(=N)N)cc1C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
RAB9A P51151 2/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.42
POLB P06746 1/20 0.41
ADRA2A P08913 4/20 0.40
MAOA P21397 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2C P28335 1/20 0.40
SLC6A4 P31645 1/20 0.40
HTR2B P41595 1/20 0.40
PLAU P00749 2/20 0.39
MAPT P10636 1/20 0.39
HSP90AA1 P07900 1/20 0.37
TLR9 Q9NR96 1/20 0.37
TMPRSS2 O15393 1/20 0.37
NPC1 O15118 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13017232 0.91 CYP1A2 (0.42) CYP1A2RAB9AKMT2ACYP3A4POLB
SCHEMBL3736944 0.90 RAB9A (0.53) CYP1A2RAB9AKMT2ACYP3A4POLB
Hydrochloric Acid SCHEMBL3727655 0.89 RAB9A (0.51) CYP1A2RAB9AKMT2ACYP3A4POLB
SCHEMBL3771009 0.81 PLAU (0.57) CYP1A2RAB9AKMT2ACYP3A4POLB
SCHEMBL3783652 0.81 ADRA2A (0.55) RAB9AKMT2APOLBADRA2APLAU
SCHEMBL10310209 0.79 PLAU (0.40) RAB9AKMT2APOLBADRA2APLAU
SCHEMBL1996992 0.75 F2 (0.50) RAB9ACYP3A4MAPTNPC1F2
Hydrochloric Acid SCHEMBL1789491 0.72 ROCK2 (0.45) CYP3A4MAOATMPRSS2
SCHEMBL6289112 0.71 TDP1 (0.37) RAB9AKMT2ACYP3A4PLAUMAPT
SCHEMBL11596366 0.71 SNCA (0.44) MAOAPLAUF2PLATPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331384-A1 GUANIDINE BASED COMPOUNDS UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA (ES) 2010-12-30 US disclosed
US-20100331384-A1 GUANIDINE BASED COMPOUNDS UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA (ES) 2010-12-30 US disclosed
US-20100331384-A1 GUANIDINE BASED COMPOUNDS UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA (ES) 2010-12-30 US disclosed
WO-2009080818-A2 GUANIDINE BASED COMPOUNDS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2009-07-02 WO disclosed
WO-2009080818-A2 GUANIDINE BASED COMPOUNDS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331384-A1 GUANIDINE BASED COMPOUNDS ADRB2, ADRA2A, ADRA2C CYP1A2 304/4885RAB9A 648/4885KMT2A 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.